Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

Abstract Introduction The relationship between sodium glucose co-transporter 2 inhibitors (SGLT2i) and trimethylamine N-oxide (TMAO) following acute myocardial infarction (AMI) is not yet explored. Methods In this secondary analysis of the EMMY trial (ClinicalTrials.gov registration: NCT03087773), c...

Full description

Bibliographic Details
Main Authors: Faisal Aziz, Norbert J. Tripolt, Peter N. Pferschy, Ewald Kolesnik, Harald Mangge, Pero Curcic, Markus Hermann, Andreas Meinitzer, Dirk von Lewinski, Harald Sourij, the EMMY Investigators
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Cardiovascular Diabetology
Subjects:
Clinical trial
RCT
Empagliflozin
Heart failure
Myocardial infarction
Trimethylamine N-oxide
Online Access:https://doi.org/10.1186/s12933-023-01920-6

Internet

https://doi.org/10.1186/s12933-023-01920-6

Similar Items